デフォルト表紙
市場調査レポート
商品コード
1597796

手術シミュレーション市場:手術タイプ別、最終用途別-2025-2030年の世界予測

Surgical Simulation Market by Surgery Type (Cardiac Surgery/Interventional Cardiology, Gastroenterology, Neurosurgery), End-use (Hospitals, Specialty Centres) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 190 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
手術シミュレーション市場:手術タイプ別、最終用途別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

手術シミュレーション市場は、2023年に3億9,680万米ドルと評価され、2024年には4億4,862万米ドルに達すると予測され、CAGR 13.54%で成長し、2030年には9億6,540万米ドルに達すると予測されています。

手術シミュレーションとは、仮想現実(VR)、拡張現実(AR)、高忠実度マネキンなどの先端技術を使用して、トレーニングや技能向上のために外科手術を模倣することを指します。手術シミュレーターの必要性が高まっている背景には、患者の安全性が重視されるようになったこと、医療ミスを減らす必要があること、リスクのない環境で複雑な手術を練習できるメリットがあることなどがあります。これらのシミュレータは、医療学校、病院、トレーニングセンターで重要な用途を見つけ、低侵襲手技から大手術まで、外科手術の現実的な練習を容易にします。最終用途の範囲は、教育部門、ヘルスケアトレーニング機関、スタッフの熟練度と運用準備の強化を目指す病院にまたがります。主な成長要因としては、シミュレーションツールの技術的進歩、ヘルスケア投資の増加、高齢化と慢性疾患の蔓延による熟練した外科専門家に対する世界の需要の急増などが挙げられます。個別化されたトレーニングモジュールのためのAIと機械学習の統合や、遠隔学習ニーズに対応するためのオンライン、クラウドベースのシミュレーションプラットフォームの拡大にビジネスチャンスがあります。企業は、ハイテク企業や教育機関と戦略的パートナーシップを結び、シミュレーションの提供を強化することで、こうした機会を活用することができます。しかし、高コスト、継続的なアップデートの必要性、新興国でのアクセスの制限といった制約が、普及の課題となっています。さらに、セットアップや操作に専門的な技術的知識が必要なことも、資源に制約のある環境では障壁となり得る。技術革新は、シミュレーション技術のコスト削減、拡張性の確保、触覚体験を向上させるためのよりリアルな触覚フィードバックシステムの導入に重点を置くべきです。この市場は、急速な技術革新と、技術革新を目指す主要企業間の激しい競争が特徴です。このダイナミックな市場情勢の中で確固たる足場を築くことを目指す企業にとって、進化する技術動向と規制状況に常に敏感であることは極めて重要です。

主な市場の統計
基準年[2023] 3億9,680万米ドル
予測年[2024] 4億4,862万米ドル
予測年[2030] 9億6,540万米ドル
CAGR(%) 13.54%

市場力学:急速に進化する手術シミュレーション市場の主要市場インサイトを公開

手術シミュレーション市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 外科手術を必要とする慢性・急性疾患の増加
    • 人口の高齢化と外科手術件数の増加
    • 低侵襲外科手術への嗜好の高まり
  • 市場抑制要因
    • 定期的な更新の必要性と高いメンテナンスコスト
  • 市場機会
    • 高度なヘルスケアインフラの利用可能性、有利な医療保険と償還シナリオ
    • 手術シミュレーションにおける3Dプリンティングの受容
  • 市場の課題
    • 新薬のシミュレーションの有効性の欠如

ポーターの5つの力:手術シミュレーション市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:手術シミュレーション市場における外部からの影響の把握

外部マクロ環境要因は、手術シミュレーション市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析手術シミュレーション市場における競合情勢の把握

手術シミュレーション市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス手術シミュレーション市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、手術シミュレーション市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨手術シミュレーション市場における成功への道筋を描く

手術シミュレーション市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 外科手術を必要とする慢性および急性疾患の増殖
      • 高齢化の進行と外科手術件数の増加
      • 低侵襲手術への関心の高まり
    • 抑制要因
      • 定期的なアップデートと高額なメンテナンスコストが必要
    • 機会
      • 高度なヘルスケアインフラと有利な医療保険および医療費償還シナリオの利用可能性
      • 手術シミュレーションにおける3Dプリントの受け入れ
    • 課題
      • 新薬のシミュレーションの有効性の欠如
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 手術シミュレーション市場手術の種類別

  • 心臓外科/インターベンショナル心臓病学
  • 消化器内科
  • 脳神経外科
  • 腫瘍外科
  • 整形外科
  • 再建手術
  • 移植

第7章 手術シミュレーション市場:最終用途別

  • 病院
  • 専門センター

第8章 南北アメリカの手術シミュレーション市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の手術シミュレーション市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの手術シミュレーション市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • 3B Scientific GmbH
  • 3D Systems, Inc.
  • CAE Inc.
  • DiaMedical USA
  • Gaumard Scientific Company, Inc.
  • Laerdal Medical AS
  • Limbs & Things
  • Mentice AB
  • Simendo B.V.
  • Simulab Corporation
  • Startasys Ltd.
  • VirtaMed AG
  • Virti
  • Vosaic
  • VRmagic Holding AG
図表

LIST OF FIGURES

  • FIGURE 1. SURGICAL SIMULATION MARKET RESEARCH PROCESS
  • FIGURE 2. SURGICAL SIMULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SURGICAL SIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. SURGICAL SIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. SURGICAL SIMULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SURGICAL SIMULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SURGICAL SIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SURGICAL SIMULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY CARDIAC SURGERY/INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY ONCOLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY TRANSPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SIMULATION MARKET SIZE, BY SPECIALTY CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES SURGICAL SIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA SURGICAL SIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM SURGICAL SIMULATION MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM SURGICAL SIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SURGICAL SIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. SURGICAL SIMULATION MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-3A2E844FD4D9

The Surgical Simulation Market was valued at USD 396.80 million in 2023, expected to reach USD 448.62 million in 2024, and is projected to grow at a CAGR of 13.54%, to USD 965.40 million by 2030.

Surgical simulation refers to the use of advanced technology, such as virtual reality (VR), augmented reality (AR), and high-fidelity mannequins, to mimic surgical procedures for training and skills enhancement. The growing necessity of surgical simulators is driven by the increasing emphasis on patient safety, the need for reducing medical errors, and the benefits of practicing complex surgeries in a risk-free environment. These simulators find critical applications in medical schools, hospitals, and training centers, facilitating the realistic practice of surgical procedures ranging from minimally invasive techniques to major surgeries. The end-use scope spans across education sectors, healthcare training institutions, and hospitals seeking to bolster staff proficiency and operational readiness. Key growth influencers include technological advancements in simulation tools, rising healthcare investments, and the global surge in demand for skilled surgical professionals due to aging populations and chronic disease prevalence. Opportunities lie in the integration of AI and machine learning for personalized training modules and the expansion of online, cloud-based simulation platforms to cater to remote learning needs. Companies could capitalize on these opportunities by forming strategic partnerships with tech firms and educational institutions to enhance simulation offerings. However, limitations such as high costs, requirement for continuous updates, and limited access in emerging economies can pose challenges to widespread adoption. Additionally, the need for specialized technical expertise for setup and operation can be a barrier in resource-constrained settings. Innovation should focus on reducing the cost of simulation technologies, ensuring scalability, and incorporating more realistic haptic feedback systems to improve tactile experiences. The market is characterized by rapid technological advancements and intense competition among key players striving for innovation. Staying attuned to evolving technological trends and regulatory standards will be crucial for businesses aiming to establish a robust foothold in this dynamic market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 396.80 million
Estimated Year [2024] USD 448.62 million
Forecast Year [2030] USD 965.40 million
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Surgical Simulation Market

The Surgical Simulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Proliferating chronic and acute disease requiring surgical procedures
    • Prevalence of aging population and increase in number of surgical procedures
    • Rising preference for minimally invasive surgical procedures
  • Market Restraints
    • Need for regular updation and high maintenance cost
  • Market Opportunities
    • Availability of advanced healthcare infrastructure and favorable medical insurance and reimbursement scenario
    • Acceptance of 3D printing in surgical simulation
  • Market Challenges
    • Lack of efficacy of simulation of new drug

Porter's Five Forces: A Strategic Tool for Navigating the Surgical Simulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Surgical Simulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Surgical Simulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Surgical Simulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Surgical Simulation Market

A detailed market share analysis in the Surgical Simulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Surgical Simulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Surgical Simulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Surgical Simulation Market

A strategic analysis of the Surgical Simulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Surgical Simulation Market, highlighting leading vendors and their innovative profiles. These include 3B Scientific GmbH, 3D Systems, Inc., CAE Inc., DiaMedical USA, Gaumard Scientific Company, Inc., Laerdal Medical AS, Limbs & Things, Mentice AB, Simendo B.V., Simulab Corporation, Startasys Ltd., VirtaMed AG, Virti, Vosaic, and VRmagic Holding AG.

Market Segmentation & Coverage

This research report categorizes the Surgical Simulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgery Type, market is studied across Cardiac Surgery/Interventional Cardiology, Gastroenterology, Neurosurgery, Oncology Surgery, Orthopedic Surgery, Reconstructive Surgery, and Transplants.
  • Based on End-use, market is studied across Hospitals and Specialty Centres.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferating chronic and acute disease requiring surgical procedures
      • 5.1.1.2. Prevalence of aging population and increase in number of surgical procedures
      • 5.1.1.3. Rising preference for minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Need for regular updation and high maintenance cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of advanced healthcare infrastructure and favorable medical insurance and reimbursement scenario
      • 5.1.3.2. Acceptance of 3D printing in surgical simulation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of efficacy of simulation of new drug
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Surgical Simulation Market, by Surgery Type

  • 6.1. Introduction
  • 6.2. Cardiac Surgery/Interventional Cardiology
  • 6.3. Gastroenterology
  • 6.4. Neurosurgery
  • 6.5. Oncology Surgery
  • 6.6. Orthopedic Surgery
  • 6.7. Reconstructive Surgery
  • 6.8. Transplants

7. Surgical Simulation Market, by End-use

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Specialty Centres

8. Americas Surgical Simulation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Surgical Simulation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Surgical Simulation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3B Scientific GmbH
  • 2. 3D Systems, Inc.
  • 3. CAE Inc.
  • 4. DiaMedical USA
  • 5. Gaumard Scientific Company, Inc.
  • 6. Laerdal Medical AS
  • 7. Limbs & Things
  • 8. Mentice AB
  • 9. Simendo B.V.
  • 10. Simulab Corporation
  • 11. Startasys Ltd.
  • 12. VirtaMed AG
  • 13. Virti
  • 14. Vosaic
  • 15. VRmagic Holding AG